These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11689164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington's disease transgenic mice.
    Deckel AW, Tang V, Nuttal D, Gary K, Elder R.
    Brain Res; 2002 Jun 07; 939(1-2):76-86. PubMed ID: 12020853
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reduced neuronal injury after treatment with NG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion.
    Gahm C, Danilov A, Holmin S, Wiklund PN, Brundin L, Mathiesen T.
    Neurosurgery; 2005 Dec 07; 57(6):1272-81; discussion 1272-81. PubMed ID: 16331176
    [Abstract] [Full Text] [Related]

  • 5. Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice.
    Deckel AW, Volmer P, Weiner R, Gary KA, Covault J, Sasso D, Schmerler N, Watts D, Yan Z, Abeles I.
    Brain Res; 2000 Sep 01; 875(1-2):187-95. PubMed ID: 10967315
    [Abstract] [Full Text] [Related]

  • 6. Reduced ventromedial hypothalamic neuronal nitric oxide synthase and increased sensitivity to NOS inhibition in dietary obese rats: further evidence of a role for nitric oxide in the regulation of energy balance.
    Sadler CJ, Wilding JP.
    Brain Res; 2004 Aug 06; 1016(2):222-8. PubMed ID: 15246858
    [Abstract] [Full Text] [Related]

  • 7. Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation.
    Pérez-Severiano F, Escalante B, Vergara P, Ríos C, Segovia J.
    Brain Res; 2002 Sep 27; 951(1):36-42. PubMed ID: 12231454
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
    Handy RL, Harb HL, Wallace P, Gaffen Z, Whitehead KJ, Moore PK.
    Br J Pharmacol; 1996 Sep 27; 119(2):423-31. PubMed ID: 8886430
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of nitric oxide in salivary secretion.
    Lomniczi A, Suburo AM, Elverdin JC, Mastronardi CA, Diaz S, Rettori V, McCann SM.
    Neuroimmunomodulation; 1998 Sep 27; 5(5):226-33. PubMed ID: 9730690
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Time-dependent aggravation or attenuation of lipopolysaccharide-induced gastric injury by nitric oxide synthase inhibition.
    Suliburk JW, Helmer KS, Kennison SD, Mercer DW, Robinson EK.
    J Surg Res; 2005 Dec 27; 129(2):265-71. PubMed ID: 16026802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Different mechanisms underlie the effects of acute and long-term inhibition of nitric oxide synthases in antigen-induced pulmonary eosinophil recruitment in BALB/C mice.
    Lintomen L, Souza-Filho LG, Ferreira T, Camargo EA, Teixeira SA, Muscará MN, Landgraf RG, Jancar S, Mendes GD, De Nucci G, Antunes E.
    Pulm Pharmacol Ther; 2009 Feb 27; 22(1):1-8. PubMed ID: 19010435
    [Abstract] [Full Text] [Related]

  • 18. Nitric oxide and nitric oxide synthase in Huntington's disease.
    Deckel AW.
    J Neurosci Res; 2001 Apr 15; 64(2):99-107. PubMed ID: 11288139
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
    Pfeiffer S, Leopold E, Schmidt K, Brunner F, Mayer B.
    Br J Pharmacol; 1996 Jul 15; 118(6):1433-40. PubMed ID: 8832069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.